With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
State Sen. Jarrett Keohokalole joins Spotlight Now for an in-depth conversation on the issues shaping Hawaiʻi’s First Congressional District race and what he says are his priorities for Washington.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results